Custom surgical implant startup using AI lands 96 investors for $12M in new cash – WRALTechWire
restor3d is a Duke University orthopedic medical device start-up spun out of the lab of Professor Ken Gall (MEMS, Pratt)
Duke Surgical Resident is Building a Medical Device Company
Muath Bishawi M.D. Ph.D reflects on his innovation journey as his start-up, Lacuna Medical, receives seed financing led by Duke Capital Partners
Tune Therapeutics Unveils Breakthrough Data Showing Stable and Durable Epigenetic Regulation in Non-Human Primates
Tune Therapeutics is a Duke University start-up developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).
ImmunoForge Expands Drug Development Licensing Agreement with Duke University
The elastin-like polypeptide (ELP) platform acquired by ImmunoForge was developed by Dr. Ashutosh Chilkoti (BME, Pratt).
Duke Capital Partners Leads Investment in Reselute
Reselute, founded around Duke technology by a Duke professor and graduates, is developing solutions to orthopedic infections
Can I cure my diabetes with stem cells? Minutia TEDx talk
Minutia is a next generation cell therapy start-up co-founded by Professor Tuan Vo-Dinh (BME, Pratt), in part based on tech developed in his lab.
Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models
Ten63 is a Duke University start-up founded by Professor Bruce Donald (Computer Science, Trinity), and his students. Ten63 is also a Duke Capital Partners portfolio company.
April Conference Aims to Align Health Care Innovation in North Carolina
“As part of the Duke University community, we are excited about this uniquely collaborative event,” said Jeff Welch, Ph.D., director of Duke New Ventures at Duke University.
Ginkgo Bioworks Strengthens End-to-End R&D Capabilities in Gene Therapy through Acquisition of StrideBio’s AAV Capsid Discovery and Engineering Platform Assets
StrideBio was co-founded by Dr. Aravind Asokan (Surgery, SOM) and the company entered into sponsored research and licensing agreements for technology developed in his Duke lab.